Nutraceutical ingredients Market Size to Hit USD 191.04 Billion by 2034

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers

Chapter 7. Global Nutraceutical Ingredients Market, By Product

7.1. Nutraceutical Ingredients Market, by Product Type
7.1.1. Probiotic
7.1.1.1. Market Revenue and Forecast
7.1.2. Proteins and amino acids
7.1.2.1. Market Revenue and Forecast
7.1.3. Phytochemical & plant extracts
7.1.3.1. Market Revenue and Forecast
7.1.4. Fibers & specialty carbohydrates
7.1.4.1. Market Revenue and Forecast
7.1.5. Omega 3 fatty acids
7.1.5.1. Market Revenue and Forecast
7.1.6. Vitamins
7.1.6.1. Market Revenue and Forecast
7.1.7. Prebiotic
7.1.7.1. Market Revenue and Forecast
7.1.8. Carotenoids
7.1.8.1. Market Revenue and Forecast
7.1.9. Minerals
7.1.9.1. Market Revenue and Forecast
7.1.10. Others
7.1.10.1. Market Revenue and Forecast

Chapter 8. Global Nutraceutical Ingredients Market, By Application

8.1. Nutraceutical Ingredients Market, by Application

8.1.1. Food
8.1.1.1. Market Revenue and Forecast
8.1.2. Beverages
8.1.2.1. Market Revenue and Forecast
8.1.3. Personal care
8.1.3.1. Market Revenue and Forecast
8.1.4. Animal nutrition
8.1.4.1. Market Revenue and Forecast
8.1.5. Dietary supplements
8.1.5.1. Market Revenue and Forecast

Chapter 9. Global Nutraceutical Ingredients Market, By Health Benefits

9.1. Nutraceutical Ingredients Market, by Health Benefits
9.1.1. Cognitive health
9.1.1.1. Market Revenue and Forecast
9.1.2. Gut health
9.1.2.1. Market Revenue and Forecast
9.1.3. Heart health
9.1.3.1. Market Revenue and Forecast
9.1.4. Bone health
9.1.4.1. Market Revenue and Forecast
9.1.5. Immunity
9.1.5.1. Market Revenue and Forecast
9.1.6. Nutrition
9.1.6.1. Market Revenue and Forecast
9.1.7. Weigh management
9.1.7.1. Market Revenue and Forecast
9.1.8. Others
9.1.8.1. Market Revenue and Forecast

Chapter 10. Global Nutraceutical Ingredients Market, By Form

10.1. Nutraceutical Ingredients Market, by Form
10.1.1. Dry
10.1.1.1. Market Revenue and Forecast
10.1.2. Liquid
10.1.2.1. Market Revenue and Forecast

Chapter 11. Global Nutraceutical Ingredients Market, Regional Estimates and Trend Forecast

11.1. North America
11.1.1. Market Revenue and Forecast, by Product
11.1.2. Market Revenue and Forecast, by Application
11.1.3. Market Revenue and Forecast, by Health Benefits
11.1.4. Market Revenue and Forecast, by Form
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Product
11.1.5.2. Market Revenue and Forecast, by Application
11.1.5.3. Market Revenue and Forecast, by Health Benefits
11.1.5.4. Market Revenue and Forecast, by Form
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Product
11.1.6.2. Market Revenue and Forecast, by Application
11.1.6.3. Market Revenue and Forecast, by Health Benefits
11.1.6.4. Market Revenue and Forecast, by Form
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product
11.2.2. Market Revenue and Forecast, by Application
11.2.3. Market Revenue and Forecast, by Health Benefits
11.2.4. Market Revenue and Forecast, by Form
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Product
11.2.5.2. Market Revenue and Forecast, by Application
11.2.5.3. Market Revenue and Forecast, by Health Benefits
11.2.5.4. Market Revenue and Forecast, by Form
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Product
11.2.6.2. Market Revenue and Forecast, by Application
11.2.6.3. Market Revenue and Forecast, by Health Benefits
11.2.6.4. Market Revenue and Forecast, by Form
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Product
11.2.7.2. Market Revenue and Forecast, by Application
11.2.7.3. Market Revenue and Forecast, by Health Benefits
11.2.7.4. Market Revenue and Forecast, by Form
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Product
11.2.8.2. Market Revenue and Forecast, by Application
11.2.8.3. Market Revenue and Forecast, by Health Benefits
11.2.8.4. Market Revenue and Forecast, by Form
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product
11.3.2. Market Revenue and Forecast, by Application
11.3.3. Market Revenue and Forecast, by Health Benefits
11.3.4. Market Revenue and Forecast, by Form
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Product
11.3.5.2. Market Revenue and Forecast, by Application
11.3.5.3. Market Revenue and Forecast, by Health Benefits
11.3.5.4. Market Revenue and Forecast, by Form
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Product
11.3.6.2. Market Revenue and Forecast, by Application
11.3.6.3. Market Revenue and Forecast, by Health Benefits
11.3.6.4. Market Revenue and Forecast, by Form
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Product
11.3.7.2. Market Revenue and Forecast, by Application
11.3.7.3. Market Revenue and Forecast, by Health Benefits
11.3.7.4. Market Revenue and Forecast, by Form
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Product
11.3.8.2. Market Revenue and Forecast, by Application
11.3.8.3. Market Revenue and Forecast, by Health Benefits
11.3.8.4. Market Revenue and Forecast, by Form
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product
11.4.2. Market Revenue and Forecast, by Application
11.4.3. Market Revenue and Forecast, by Health Benefits
11.4.4. Market Revenue and Forecast, by Form
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Product
11.4.5.2. Market Revenue and Forecast, by Application
11.4.5.3. Market Revenue and Forecast, by Health Benefits
11.4.5.4. Market Revenue and Forecast, by Form
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Product
11.4.6.2. Market Revenue and Forecast, by Application
11.4.6.3. Market Revenue and Forecast, by Health Benefits
11.4.6.4. Market Revenue and Forecast, by Form
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Product
11.4.7.2. Market Revenue and Forecast, by Application
11.4.7.3. Market Revenue and Forecast, by Health Benefits
11.4.7.4. Market Revenue and Forecast, by Form
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Product
11.4.8.2. Market Revenue and Forecast, by Application
11.4.8.3. Market Revenue and Forecast, by Health Benefits
11.4.8.4. Market Revenue and Forecast, by Form
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product
11.5.2. Market Revenue and Forecast, by Application
11.5.3. Market Revenue and Forecast, by Health Benefits
11.5.4. Market Revenue and Forecast, by Form
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Product
11.5.5.2. Market Revenue and Forecast, by Application
11.5.5.3. Market Revenue and Forecast, by Health Benefits
11.5.5.4. Market Revenue and Forecast, by Form
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Product
11.5.6.2. Market Revenue and Forecast, by Application
11.5.6.3. Market Revenue and Forecast, by Health Benefits
11.5.6.4. Market Revenue and Forecast, by Form

Chapter 12. Company Profiles

12.1. Kraft Heinz Company
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. GlaxoSmithKline
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Amway
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Abbott
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Kellogg’s
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Danone
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Cargill Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Nestle
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Archer Daniels Midland
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. DSM
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
12.11. BASF
12.11.1. Company Overview
12.11.2. Product Offerings
12.11.3. Financial Performance
12.11.4. Recent Initiatives
12.12. General Mills
12.12.1. Company Overview
12.12.2. Product Offerings
12.12.3. Financial Performance
12.12.4. Recent Initiatives
12.13. Aker Biomarine
12.13.1. Company Overview
12.13.2. Product Offerings
12.13.3. Financial Performance
12.13.4. Recent Initiatives
12.14. Procter & Gamble
12.14.1. Company Overview
12.14.2. Product Offerings
12.14.3. Financial Performance
12.14.4. Recent Initiatives
12.15. Johnson & Johnson
12.15.1. Company Overview
12.15.2. Product Offerings
12.15.3. Financial Performance
12.15.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions

Chapter 14. Appendix

14.1. About Us
14.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global nutraceutical ingredients market size is valued at USD 95.73 billion in 2025 and expected to be worth USD 191.04 billion by 2034.

The global nutraceutical ingredients market is growing with a compound annual growth rate (CAGR) of 7.98% during the forecast period 2025 to 2034.

Asia Pacific showed prominent growth in the global Nutraceutical Ingredients market in 2024 because of growing demand for nutraceutical products.

The key players are operating the nutraceutical ingredients market are Kraft Heinz Company, GlaxoSmithKline, Amway, Abbott, Kelloggâ€™s, Danone, Cargill Inc., Nestle, Archer Daniels Midland, DSM, BASF, PepsiCo, General Mills, Aker Biomarine, Procter & Gamble, and Johnson & Johnson

The global nutraceutical ingredients market growth is driven by factors such as the growth in demand for fortified foods due to a rising knowledge of health among consumers. Growing incidences of chronic diseases globally and mandates for food fortification by government organisations are key drivers for the growth of the industry. Different producers of nutraceutical ingredients are increasingly embracing personalised healthcare innovations to formulate better-suited and tailored end products for customers. Increasingly, consumer product businesses are now gathering data to allow a proper analysis of buying habits and lifestyle and provide customers with personalised choices in line with their buying trends. The global nutraceutical ingredients market has been driven by growth in life ex